Recommended

Discover how to overcome low affinity or poor TCR yields that are slowing you down in this upcoming webinar – register your details today
WEBINAR | Discover how advances can expand the possibilities for drug discovery, from target validation to preclinical development
Facing roadblocks in obesity drug discovery? Discover how integrated, validated strategies are helping teams accelerate development and reduce risk – register your details now
Unlock the science, strategy and real-world impact behind the next generation of precision therapies – access our new brand report now >>
Safety data is no longer just a regulatory checkbox – it’s a strategic advantage. Find out more in our upcoming webinar, register your details today
WEBINAR | Join top cancer researchers to explore advances transforming early discovery, from new targets and models to the therapies of tomorrow

List view / Grid view

Aaron Risinger (Director of Business Development for Cellular Workflow Automation at Molecular Devices)

 

Illustration of a human figure showing the location and types of organoids used in biomedical research, including mammary gland, liver, intestinal, cerebral, lung, and stomach organoids.
Illustration of a human figure showing the location and types of organoids used in biomedical research, including mammary gland, liver, intestinal, cerebral, lung, and stomach organoids.
article

Building reliable organoid models for human-relevant drug discovery

Organoids are changing the landscape of biomedical research, with automation…

17 October 2025 | By

Organoids are changing the landscape of biomedical research, with automation and AI driving new levels of consistency, scalability and human relevance. Aaron Risinger of Molecular Devices discusses how these technologies are advancing precision medicine – and the challenges that remain.